SNS-301

SNS-301 · Sensei Biotherapeutics, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for SNS-301, covering 2022-12-30 to 2022-12-30. Get the full timeline:

Most recent: Clinical Trial Update: Addition of SNS-301 to Checkpoint Inhibitor Treatment in Metastatic/Recurrent SCCHN [Phase 1, Phase 2]